Back

Should device therapy in hypertension be documented to lower morbidity and mortality before inclusion in routine treatment?

30 August 2016 (17:37 - 18:00)
Organised by:
Congress Presentation Part of: Device therapy in hypertension Devices / interventions ESC Premium Access ESC Congress 2016

About the speaker

Photo
Professor John Cleland

University of Glasgow, Glasgow (United Kingdom of Great Britain & Northern Ireland)

3 More presentations in this session

Presentation thumbnail
Renal denervation
Professor F. Mahfoud (Basel, CH)
Slides Video
Presentation thumbnail
Baroreceptor activation
Professor P. De Leeuw (Maastricht, NL)
Slides Video
Presentation thumbnail
Other devices
Professor A. Pathak (Luxembourg, LU)
Slides Video

Access the full session

Session thumbnail
Device therapy in hypertension

The Event

Event poster

ESC Congress 2016

30 August 2016 17:37 CET
You may be interested in
thumbnail
Congress Presentation
Randomized controlled pilot study comparing different digital solutions for the management of hypertensive patients: the HSMonitor-IT study.
5 April 2025
thumbnail
Congress Session
When to consider device therapy in HFrEF
20 May 2025
thumbnail
Congress Presentation
Hypertension in thoracic aortic aneurysm and dissection: considerations in the choice of antihypertensive agents for the long-term management
1 September 2025
thumbnail
Congress Presentation
The relationship between blood pressure and mortality in the general population - it is not as simple as one might think - results from 20 years follow-up in the Study of Health in Pomerania
25 April 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources